相关实验视频

Updated: Jun 4, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

一个患有互白素-2-诱导性T细胞激酶缺乏症患者的多种瘤:一个病例报告

Michela Di Filippo¹, Ramona Tallone², Monica Muraca²

¹Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics and Maternal-Infantile Sciences, University of Genoa, 16147 Genoa, Italy.

International journal of molecular sciences

|December 17, 2024

概括

天生的免疫错误 (IEI) 可以导致各种健康问题,包括癌症. 这一案例凸显了ITK基因突变和先前的癌症治疗如何在幸存者中引起复杂的免疫问题和新的瘤.

科学领域:

免疫学免疫学免疫学
遗传学遗传学是一个
在瘤学瘤学.

背景情况:

免疫的先天性错误 (IEI) 存在各种表型,包括自身免疫性疾病,淋巴增殖和癌症,与许多基因有关.
儿童癌症幸存者 (CCSs) 可能有免疫异常,可能表明潜在的IEI,并面临治疗导致二次恶性瘤的风险增加.

研究的目的:

描述一个患有ITK基因变异,多种瘤和免疫失调的患者的独特病例.
在儿童癌症幸存者中探索遗传免疫障碍和二次恶性瘤之间的相互作用.

主要方法:

在基因分析中,鉴定出了交联素-2-诱导性T细胞激酶 (ITK) 基因中复合的异构性致病变体.
临床和免疫学分析显示CD4+淋巴细胞衰减,记忆B细胞缺乏,调控T细胞减少和B/T细胞激活.

主要成果:

该患者出现了复发的与爱斯坦-巴尔病毒相关的结节性硬化症和霍奇金淋巴瘤 (NSHL),手和免疫血栓塞缩症.
该患者表现出独特的临床特征,这是由于ITK相关的免疫失调和先前的瘤治疗造成的.

结论:

ITK基因变异可能导致显著的免疫失调,具有多种不同的临床表现.
IEI和癌症治疗的同时发生可能会导致独特而严重的健康结果,强调需要提高认识.

关键词:

ITK 缺陷 ITK 的缺陷案例报告案例报告儿童癌症幸存者 (CCS) 儿童癌症幸存者免疫的先天性错误 (IEI)多个瘤多个瘤.

更多相关视频

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Published on: January 24, 2020

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.